The global Automated Complete Blood Cell Counter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Automated Complete Blood Cell Counter is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Automated Complete Blood Cell Counter is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Automated Complete Blood Cell Counter include Thermo Fisher Scientific, Bio-Rad, Beckman Coulter, Merck Millipore, Roche, Olympus, ChemoMetec, Advanced Instruments and Corning, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Automated Complete Blood Cell Counter, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Complete Blood Cell Counter.
Report Scope
The Automated Complete Blood Cell Counter market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Complete Blood Cell Counter market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Complete Blood Cell Counter manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad
Beckman Coulter
Merck Millipore
Roche
Olympus
ChemoMetec
Advanced Instruments
Corning
Nexcelom Bioscience
Logos Biosystems
Oxford Optronix
DeNovix
Countstar (ALIT Life Sciences)
NanoEntek
Segment by Type
Benchtop Automated Cell Counters
Handheld Automated Cell Counters
Segment by Application
Hospital
Clinic
Biology Laboratory
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Complete Blood Cell Counter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automated Complete Blood Cell Counter in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Automated Complete Blood Cell Counter Market Overview
1.1 Product Overview and Scope of Automated Complete Blood Cell Counter
1.2 Automated Complete Blood Cell Counter Segment by Type
1.2.1 Global Automated Complete Blood Cell Counter Market Value Comparison by Type (2024-2030)
1.2.2 Benchtop Automated Cell Counters
1.2.3 Handheld Automated Cell Counters
1.3 Automated Complete Blood Cell Counter Segment by Application
1.3.1 Global Automated Complete Blood Cell Counter Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Biology Laboratory
1.3.5 Others
1.4 Global Automated Complete Blood Cell Counter Market Size Estimates and Forecasts
1.4.1 Global Automated Complete Blood Cell Counter Revenue 2019-2030
1.4.2 Global Automated Complete Blood Cell Counter Sales 2019-2030
1.4.3 Global Automated Complete Blood Cell Counter Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Automated Complete Blood Cell Counter Market Competition by Manufacturers
2.1 Global Automated Complete Blood Cell Counter Sales Market Share by Manufacturers (2019-2024)
2.2 Global Automated Complete Blood Cell Counter Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Automated Complete Blood Cell Counter Average Price by Manufacturers (2019-2024)
2.4 Global Automated Complete Blood Cell Counter Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Automated Complete Blood Cell Counter, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automated Complete Blood Cell Counter, Product Type & Application
2.7 Automated Complete Blood Cell Counter Market Competitive Situation and Trends
2.7.1 Automated Complete Blood Cell Counter Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automated Complete Blood Cell Counter Players Market Share by Revenue
2.7.3 Global Automated Complete Blood Cell Counter Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Complete Blood Cell Counter Retrospective Market Scenario by Region
3.1 Global Automated Complete Blood Cell Counter Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Automated Complete Blood Cell Counter Global Automated Complete Blood Cell Counter Sales by Region: 2019-2030
3.2.1 Global Automated Complete Blood Cell Counter Sales by Region: 2019-2024
3.2.2 Global Automated Complete Blood Cell Counter Sales by Region: 2025-2030
3.3 Global Automated Complete Blood Cell Counter Global Automated Complete Blood Cell Counter Revenue by Region: 2019-2030
3.3.1 Global Automated Complete Blood Cell Counter Revenue by Region: 2019-2024
3.3.2 Global Automated Complete Blood Cell Counter Revenue by Region: 2025-2030
3.4 North America Automated Complete Blood Cell Counter Market Facts & Figures by Country
3.4.1 North America Automated Complete Blood Cell Counter Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Automated Complete Blood Cell Counter Sales by Country (2019-2030)
3.4.3 North America Automated Complete Blood Cell Counter Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automated Complete Blood Cell Counter Market Facts & Figures by Country
3.5.1 Europe Automated Complete Blood Cell Counter Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Automated Complete Blood Cell Counter Sales by Country (2019-2030)
3.5.3 Europe Automated Complete Blood Cell Counter Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Complete Blood Cell Counter Market Facts & Figures by Country
3.6.1 Asia Pacific Automated Complete Blood Cell Counter Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Automated Complete Blood Cell Counter Sales by Country (2019-2030)
3.6.3 Asia Pacific Automated Complete Blood Cell Counter Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Automated Complete Blood Cell Counter Market Facts & Figures by Country
3.7.1 Latin America Automated Complete Blood Cell Counter Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Automated Complete Blood Cell Counter Sales by Country (2019-2030)
3.7.3 Latin America Automated Complete Blood Cell Counter Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Complete Blood Cell Counter Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Complete Blood Cell Counter Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Automated Complete Blood Cell Counter Sales by Country (2019-2030)
3.8.3 Middle East and Africa Automated Complete Blood Cell Counter Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automated Complete Blood Cell Counter Sales by Type (2019-2030)
4.1.1 Global Automated Complete Blood Cell Counter Sales by Type (2019-2024)
4.1.2 Global Automated Complete Blood Cell Counter Sales by Type (2025-2030)
4.1.3 Global Automated Complete Blood Cell Counter Sales Market Share by Type (2019-2030)
4.2 Global Automated Complete Blood Cell Counter Revenue by Type (2019-2030)
4.2.1 Global Automated Complete Blood Cell Counter Revenue by Type (2019-2024)
4.2.2 Global Automated Complete Blood Cell Counter Revenue by Type (2025-2030)
4.2.3 Global Automated Complete Blood Cell Counter Revenue Market Share by Type (2019-2030)
4.3 Global Automated Complete Blood Cell Counter Price by Type (2019-2030)
5 Segment by Application
5.1 Global Automated Complete Blood Cell Counter Sales by Application (2019-2030)
5.1.1 Global Automated Complete Blood Cell Counter Sales by Application (2019-2024)
5.1.2 Global Automated Complete Blood Cell Counter Sales by Application (2025-2030)
5.1.3 Global Automated Complete Blood Cell Counter Sales Market Share by Application (2019-2030)
5.2 Global Automated Complete Blood Cell Counter Revenue by Application (2019-2030)
5.2.1 Global Automated Complete Blood Cell Counter Revenue by Application (2019-2024)
5.2.2 Global Automated Complete Blood Cell Counter Revenue by Application (2025-2030)
5.2.3 Global Automated Complete Blood Cell Counter Revenue Market Share by Application (2019-2030)
5.3 Global Automated Complete Blood Cell Counter Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Automated Complete Blood Cell Counter Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Bio-Rad
6.2.1 Bio-Rad Corporation Information
6.2.2 Bio-Rad Description and Business Overview
6.2.3 Bio-Rad Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bio-Rad Automated Complete Blood Cell Counter Product Portfolio
6.2.5 Bio-Rad Recent Developments/Updates
6.3 Beckman Coulter
6.3.1 Beckman Coulter Corporation Information
6.3.2 Beckman Coulter Description and Business Overview
6.3.3 Beckman Coulter Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Beckman Coulter Automated Complete Blood Cell Counter Product Portfolio
6.3.5 Beckman Coulter Recent Developments/Updates
6.4 Merck Millipore
6.4.1 Merck Millipore Corporation Information
6.4.2 Merck Millipore Description and Business Overview
6.4.3 Merck Millipore Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Millipore Automated Complete Blood Cell Counter Product Portfolio
6.4.5 Merck Millipore Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roche Automated Complete Blood Cell Counter Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Olympus
6.6.1 Olympus Corporation Information
6.6.2 Olympus Description and Business Overview
6.6.3 Olympus Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Olympus Automated Complete Blood Cell Counter Product Portfolio
6.6.5 Olympus Recent Developments/Updates
6.7 ChemoMetec
6.6.1 ChemoMetec Corporation Information
6.6.2 ChemoMetec Description and Business Overview
6.6.3 ChemoMetec Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ChemoMetec Automated Complete Blood Cell Counter Product Portfolio
6.7.5 ChemoMetec Recent Developments/Updates
6.8 Advanced Instruments
6.8.1 Advanced Instruments Corporation Information
6.8.2 Advanced Instruments Description and Business Overview
6.8.3 Advanced Instruments Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Advanced Instruments Automated Complete Blood Cell Counter Product Portfolio
6.8.5 Advanced Instruments Recent Developments/Updates
6.9 Corning
6.9.1 Corning Corporation Information
6.9.2 Corning Description and Business Overview
6.9.3 Corning Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Corning Automated Complete Blood Cell Counter Product Portfolio
6.9.5 Corning Recent Developments/Updates
6.10 Nexcelom Bioscience
6.10.1 Nexcelom Bioscience Corporation Information
6.10.2 Nexcelom Bioscience Description and Business Overview
6.10.3 Nexcelom Bioscience Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nexcelom Bioscience Automated Complete Blood Cell Counter Product Portfolio
6.10.5 Nexcelom Bioscience Recent Developments/Updates
6.11 Logos Biosystems
6.11.1 Logos Biosystems Corporation Information
6.11.2 Logos Biosystems Automated Complete Blood Cell Counter Description and Business Overview
6.11.3 Logos Biosystems Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Logos Biosystems Automated Complete Blood Cell Counter Product Portfolio
6.11.5 Logos Biosystems Recent Developments/Updates
6.12 Oxford Optronix
6.12.1 Oxford Optronix Corporation Information
6.12.2 Oxford Optronix Automated Complete Blood Cell Counter Description and Business Overview
6.12.3 Oxford Optronix Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Oxford Optronix Automated Complete Blood Cell Counter Product Portfolio
6.12.5 Oxford Optronix Recent Developments/Updates
6.13 DeNovix
6.13.1 DeNovix Corporation Information
6.13.2 DeNovix Automated Complete Blood Cell Counter Description and Business Overview
6.13.3 DeNovix Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.13.4 DeNovix Automated Complete Blood Cell Counter Product Portfolio
6.13.5 DeNovix Recent Developments/Updates
6.14 Countstar (ALIT Life Sciences)
6.14.1 Countstar (ALIT Life Sciences) Corporation Information
6.14.2 Countstar (ALIT Life Sciences) Automated Complete Blood Cell Counter Description and Business Overview
6.14.3 Countstar (ALIT Life Sciences) Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Countstar (ALIT Life Sciences) Automated Complete Blood Cell Counter Product Portfolio
6.14.5 Countstar (ALIT Life Sciences) Recent Developments/Updates
6.15 NanoEntek
6.15.1 NanoEntek Corporation Information
6.15.2 NanoEntek Automated Complete Blood Cell Counter Description and Business Overview
6.15.3 NanoEntek Automated Complete Blood Cell Counter Sales, Revenue and Gross Margin (2019-2024)
6.15.4 NanoEntek Automated Complete Blood Cell Counter Product Portfolio
6.15.5 NanoEntek Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Complete Blood Cell Counter Industry Chain Analysis
7.2 Automated Complete Blood Cell Counter Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Complete Blood Cell Counter Production Mode & Process
7.4 Automated Complete Blood Cell Counter Sales and Marketing
7.4.1 Automated Complete Blood Cell Counter Sales Channels
7.4.2 Automated Complete Blood Cell Counter Distributors
7.5 Automated Complete Blood Cell Counter Customers
8 Automated Complete Blood Cell Counter Market Dynamics
8.1 Automated Complete Blood Cell Counter Industry Trends
8.2 Automated Complete Blood Cell Counter Market Drivers
8.3 Automated Complete Blood Cell Counter Market Challenges
8.4 Automated Complete Blood Cell Counter Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Thermo Fisher Scientific
Bio-Rad
Beckman Coulter
Merck Millipore
Roche
Olympus
ChemoMetec
Advanced Instruments
Corning
Nexcelom Bioscience
Logos Biosystems
Oxford Optronix
DeNovix
Countstar (ALIT Life Sciences)
NanoEntek
听
听
*If Applicable.
